Browse Studies — Arctuva

Observational

Efficacy of the Artificial Intelligence HeartBot II in Increasing Awareness and Knowledge of Heart Attack in Women: Study Protocol for a Randomized Controlled Trial With a Waitlist Control

The goal of this clinical trial is to find out whether an app-based program called HeartBot II, which uses an artificial intelligence (AI) chatbot, can help im…

Participants Must be Women Aged 25 Years or OlderParticipants Should Have no Self-reported History of Heart Disease or StrokeParticipants Should Have no Terminal Illness or Diagnosed Cognitive Impairment, Including Alzheimer's Disease+4 more

Estimated

~$10 – $5,625

Find your next paid study

Advancing Health Equity Via Basic Income + Early Childhood Systems Integration: An RCT of the Baby Bonus Program

Efficacy of the Artificial Intelligence HeartBot II in Increasing Awareness and Knowledge of Heart Attack in Women: Study Protocol for a Randomized Controlled Trial With a Waitlist Control